March 12 (Reuters) - Avid Bioservices Inc CDMO.O :
* AVID BIOSERVICES INC: HAS IDENTIFIED A MATERIAL WEAKNESS
IN
INTERNAL CONTROL OVER FINANCIAL REPORTING
* AVID BIOSERVICES : AS A RESULT OF CLASSIFICATION OF 2026
NOTES,
FINANCIALS INCLUDED IN RELEVANT REPORTS SHOULD NO LONGER BE
RELIED UPON
* AVID BIOSERVICES INC: HAS CONCLUDED THAT COMPANY'S
DISCLOSURE
CONTROLS AND PROCEDURES WERE NOT EFFECTIVE AT REASONABLE
ASSURANCE LEVEL
* AVID BIOSERVICES INC: PLANS TO PRESENT RESTATED FINANCIALS
FOR
CERTAIN OF RELEVANT PERIODS IN AN AMENDMENT TO FY 2023 10-K
Source text for Eikon: ID:n0001683168-24-001433
Further company coverage: CDMO.O
((Reuters.Briefs@thomsonreuters.com;))